BiPER Therapeutics
Debt Financing in 2024
BiPER Therapeutics is a biotechnology company focused on developing and commercializing innovative therapeutic solutions. The company specializes in creating drugs that target critical proteins involved in the metabolism of cancer cells, aiming to overcome treatment resistance and enhance cancer cell survival. Their primary focus is on providing effective treatments for gastrointestinal cancers.
Vaxinano
Venture Round in 2024
Vaxinano is a biotechnology company founded in 2016, focused on the preclinical and pharmaceutical development of vaccines and drug delivery systems for both humans and animals. Building on 25 years of research and clinical trials led by Pr Didier Betbeder, Vaxinano specializes in creating prophylactic and therapeutic vaccines for infectious diseases. The company employs safe-by-design nanoparticles that adhere to green chemistry principles, facilitating the development of drugs targeting active biomolecules, proteins, and antigens. This innovative approach enables medical researchers to create new vaccines aimed at addressing untreated viral, bacterial, and parasitic diseases.
BiPER Therapeutics
Seed Round in 2023
BiPER Therapeutics is a biotechnology company focused on developing and commercializing innovative therapeutic solutions. The company specializes in creating drugs that target critical proteins involved in the metabolism of cancer cells, aiming to overcome treatment resistance and enhance cancer cell survival. Their primary focus is on providing effective treatments for gastrointestinal cancers.
Dianosic
Seed Round in 2023
Dianosic SAS is a healthcare organization based in Strasbourg, France, founded in 2017. The company specializes in the development of advanced medical devices aimed at addressing Ear, Nose, and Throat (ENT) conditions. Dianosic's flagship products include CAVI-T, an asymmetrical intranasal balloon that effectively manages spontaneous or postoperative bleeding through low-pressure compression while adapting to the nasal cavity's unique anatomy. Additionally, the company has developed an Active Resorbable Intranasal Scaffold device designed to treat chronic sinusitis and allergic rhinitis, particularly for patients who have not responded to conventional drug treatments. This innovative scaffold is characterized by its long-acting formulation, which allows for sustained drug release over a period of six to twelve months. Dianosic aims to set new standards of care in ENT treatment, with the potential to expand its technology into other areas such as chronic migraine and facial pain management.
VistaCare Medical
Venture Round in 2022
VistaCare Medical is a French company specializing in the development, manufacturing, and distribution of innovative medical devices designed to treat acute and chronic wounds. The company focuses on non-contact wound treatment within a controlled environment, which enhances patient care and significantly reduces treatment times and hospital stays. VistaCare's technology aims to improve the quality of life for patients suffering from complex wounds and provides caregivers with tools to simplify their daily tasks. By addressing critical therapeutic needs, such as isolating nosocomial risks and enabling visual monitoring of wound progression, VistaCare facilitates personalized care tailored to the specific type and stage of each wound, ultimately advancing the standard of wound management.
Biointrant
Venture Round in 2022
BioIntrant is a company focused on enhancing agricultural productivity through innovative biotechnology solutions. It specializes in developing biofertilizers that align with environmentally responsible practices in modern agriculture. By integrating plants with their surrounding ecosystems, BioIntrant's products support plants' natural defense mechanisms, thereby improving overall plant health and productivity. The company also offers a range of services in agronomy, microbiology, biostimulation, bioinformatics, and genomics, all aimed at fostering sustainable agricultural practices and profitability.
Spartha Medical
Seed Round in 2021
Spartha Medical is a medical technology company focused on developing innovative coatings designed to enhance the safety of medical devices and consumer products. The company utilizes eco-friendly and biocompatible coatings made from natural biopolymers, which possess antibacterial, antiviral, and anti-inflammatory properties. Their patented technology allows for precise control over the assembly of two distinct polyelectrolytes, enabling the creation of versatile and multifunctional surface coatings tailored to specific applications. By providing effective solutions that protect users from microbial and inflammatory risks, Spartha Medical aims to improve healthcare outcomes and promote safer use of medical devices across various healthcare settings.
WattPark
Seed Round in 2021
WattPark is a provider of innovative charging point solutions tailored for the automobile industry. The company specializes in reservable and monetizable charging stations that empower users to select specific locations and associated services via Bluetooth technology. This functionality is particularly beneficial in areas lacking network coverage or internet access, ensuring reliable charging options for electric vehicles. By offering a mobile application that fully controls the booking process, WattPark enhances the user experience while meeting the needs of automobile clients with effective parking and charging solutions.
uvoji by T.zic
Seed Round in 2020
uvoji designs, develops, manufactures and markets all-in-one solutions for the treatment and disinfection of water at points of use and of surfaces by UV LEDs. To meet the major challenges of access to drinking water and provide technological solutions to the urgent needs of point-of-use water treatment, we launched the Oji Safe, Oji Pure and Oji Reuse products. Our solutions are used notably by the French Red Cross for its operations. In response to the Covid pandemic, we developed the Uvo Care. Uvo Care is the disinfection box, Made in France, for all types of masks and everyday objects. The essential ally for resuming your professional activities in complete safety. It has been tested and approved by independent laboratories and kills over 99.999% of viruses and bacteria in just seconds (including SARS-COV2 virus).
Lumi'In
Venture Round in 2019
Lumi'In is a manufacturer and distributor of smart solar streetlights based in Malijai, France. Established in 2014, the company specializes in designing and assembling innovative solar lighting systems, including models such as Frisbi, Caraibe, Astral, Classic, Wave, Galaxy, HCPL, and New Classic/New Style. Lumi'In's products utilize photovoltaic technology to produce electric energy, which is stored in batteries for nighttime use, offering a cleaner alternative to traditional lighting solutions. In addition to its diverse range of streetlights, the company provides smart charge regulators and various customer services, including on-site visits, brightness simulations, product customization, and power-tuning services.
gulplug
Equity Crowdfunding in 2019
Gulplug is a technology company based in Grenoble, France, founded in 2014, that specializes in developing innovative solutions for electrical connections to power grids and the Internet. The company offers a range of products designed to enhance energy efficiency and connectivity, including E-Cube wireless energy sensors, E-Case, a plug-and-play suitcase for independent energy consumption monitoring, and SELFPLUG, a rechargeable socket for electric vehicles. Additionally, Gulplug provides a web platform called Cleantech Save It Yourself, which allows users to monitor machine energy consumption. Known for its unique magnetic sensor technology, Gulplug aims to simplify everyday electrical connections while promoting energy savings and safety, catering to various industries where convenience and efficiency are paramount. The company also offers co-innovation services to tailor its products to meet specific customer needs.
Lattice Medical
Seed Round in 2018
Lattice Medical is a French company founded in 2017 that specializes in the design and manufacture of cell regeneration prostheses for women who have undergone mastectomy due to breast cancer. The company addresses the needs of a significant population, as one in eight women is diagnosed with breast cancer, and a substantial percentage undergo mastectomy procedures. Lattice Medical has developed an innovative implantable device called MATTISSE, which facilitates natural breast reconstruction by regenerating autologous adipose tissues. Utilizing advanced technologies such as biomaterials, tissue engineering, and 3D printing, MATTISSE allows for personalized reconstruction in a single surgical procedure. The device is composed of fully biodegradable materials that dissolve post-reconstruction, aiming to replace traditional silicone-based implants. This approach not only enhances the surgical experience by reducing invasiveness and pain but also significantly decreases surgery time, providing health professionals with a valuable tool for restoring patients' bodies and lives.
ffly4u
Venture Round in 2018
ffly4u SAS provides innovative solutions for tracking reusable mobile assets and transport packaging, specializing in low-frequency locating services. Founded in 2014 and based in Toulouse, France, the company offers several applications, including myDrum, myBin, myTrailer, and myEquipment, which facilitate both outdoor and indoor geolocation of various assets. These solutions cater to a wide range of industries, such as telecommunications, waste management, construction, and agriculture, by serving logistics and supply chain managers, as well as financial and operational executives. The technology combines a device for asset attachment, low-power wide-area network (LPWAN) connectivity for data transmission, and a data platform powered by ThingWorx for effective data management. This comprehensive approach positions ffly4u as a leader in embedded information for B2B mobile assets in Europe.
Virage-Viager
Venture Round in 2018
Virage-Viager, founded in 2010 and based in Paris, France, specializes in providing life insurance solutions tailored for senior citizens. The company focuses on fostering intergenerational savings, enabling seniors to maintain financial stability and quality of life as they age. Through its innovative approach, Virage-Viager aims to address the financial needs of older adults while promoting equity and support within families.
Levels3D is a French startup founded in 2012 by Yannick Folliard, specializing in 3D and augmented reality solutions. The company develops an innovative 3D scanning application compatible with next-generation tablets and smartphones that feature depth sensors. This application is tailored for professionals in consulting, architecture, general contracting, and space design, enabling them to manage and utilize 3D scans effectively. Additionally, Levels3D offers MyCaptR, a 3D scanning solution designed for professionals, alongside Smart Glasses-ERDF, a prototype augmented reality device that enhances the user experience. Through its advanced technology, Levels3D aims to transform how industries visualize and interact with spatial designs.
Pili
Venture Round in 2018
PILI Inc. is a biotechnology company based in Paris, France, that specializes in the research and manufacturing of bio-fabricated colors using microorganisms. Founded in 2012, the company focuses on developing enzymes and fermentation biotechnologies that transform sugar into renewable and durable dyes and pigments. By offering a sustainable alternative to traditional toxic and non-recyclable inks, PILI aims to replace petrochemical and vegetable-based colorants with organic dyes produced at an industrial scale. The company's innovative approach not only promotes sustainable development but also enables businesses to reduce costs while utilizing environmentally friendly materials.
Poietis is a biotechnology company focused on designing regenerative medicine therapies through 4D laser bioprinting. The company offers a unique platform for industrial stakeholders and researchers to create bio-printed products for regenerative medicine, preclinical research, and evaluating cosmetic products and ingredients. Poietis develops 3D physiological models in partnership with major pharmaceutical and cosmetic groups, enabling more predictive in vitro assessments of drug toxicity and efficacy, as well as the effectiveness of new cosmetic ingredients. The company has collaborated on projects to develop complex bio-printed products, such as bioprinting hair follicles with L'Oréal. Poietis' single-cell bioprinting platform is designed to meet industrial production requirements and clinical manufacturing standards.
1Check
Venture Round in 2017
1Check is a SaaS platform and mobile application established in 2012, dedicated to enhancing operations management within the hospitality sector. The company provides a specialized solution tailored to the unique requirements of housekeeping, maintenance, and management teams. With a presence in over 350 client sites across Europe, 1Check has garnered recognition as a leader in its field. The platform enables managers to efficiently create and organize schedules for cleaning and maintenance teams, thereby improving customer service quality and boosting team productivity. By offering intuitive technology, 1Check aims to enhance customer satisfaction, reduce staff movement, and improve working conditions for employees in the hospitality industry.
Vectalys
Venture Round in 2016
Vectalys, expert in gene delivery based on lentiviral vectors, is a private biotech company founded by Pascale Bouillé in 2005. Today, Vectalys counts 25 full-time employees exclusively dedicated to providing lentiviral vectors, cell models, molecular biology strategies and supporting your projects. Vectalys aims to help scientists worldwide understand cellular and molecular mechanisms in order to discover new drugs and therapies. Vectalys has developed a state-of-the-art proprietary technology to provide the highest quality of lentiviral vectors for the transduction of hard-to-transfect cells like primary cells, stem cells and in vivo tissues. Vectalys high quality lentiviral vectors ensure 100% transduction efficiency and non-toxic transduction on any target cells, for example to create predictive models. Because each project is unique, the Vectalys team supports you by providing custom lentiviral vectors for the right application with your gene of interest. Vectalys is also the manufacturer of highly pure ready-to-use lentiviral vectors carrying fluorescent, bioluminescent or gene editing proteins. These products are distributed worldwide. Vectalys is committed to providing solutions that save your time and support your most ambitious projects.
SUNiBrain
Venture Round in 2016
SUNiBrain is a pioneer in the development of cooling systems for photovoltaic cells, aimed at enhancing the efficiency and longevity of solar panels. The company's innovative technology utilizes rainwater to cool photovoltaic modules, effectively reducing aging and maintaining optimal performance in various temperature conditions. This natural solution not only keeps solar panels clean but also ensures maximum photoelectric efficiency over time. SUNiBrain's patented system is designed to be compatible with all types of photovoltaic installations, providing solar power producers with a cost-effective way to increase their energy output. By optimizing the performance of solar plants, SUNiBrain enables professionals to achieve above-average annual production from their photovoltaic systems.
Algo Paint
Equity Crowdfunding in 2016
Algo Paint SA, founded in 2015 and located in Vern-sur-Seiche, France, specializes in the production of eco-friendly paints derived from algae. The company has innovatively replaced fossil fuels with renewable local resources, utilizing algae from plant and natural origins as its primary raw material. Algo Paint's products are designed for both interior and exterior applications, offering a healthier alternative to traditional chemical paints. By prioritizing ecological sustainability, Algo Paint contributes to improved air quality and helps meet various environmental standards and regulations, positioning itself as a leader in the green paint industry.
StayHome SAS
Seed Round in 2016
StayHome SAS operates a real estate portage platform that supports private individuals in executing rental investments while providing assistance to property owners facing financial difficulties. The platform enables owners to temporarily sell their real estate to raise capital for debt management. Importantly, it allows these owners to remain tenants in their properties, with an agreement to repurchase the property at a predetermined price within a specified timeframe. The company’s solutions are designed to be accessible, offering flexible financing without age, health, or income criteria, catering to private and professional owners who may not qualify for traditional bank financing. Through this approach, StayHome facilitates affordable housing options for its users.
Poietis
Equity Crowdfunding in 2016
Poietis is a biotechnology company focused on designing regenerative medicine therapies through 4D laser bioprinting. The company offers a unique platform for industrial stakeholders and researchers to create bio-printed products for regenerative medicine, preclinical research, and evaluating cosmetic products and ingredients. Poietis develops 3D physiological models in partnership with major pharmaceutical and cosmetic groups, enabling more predictive in vitro assessments of drug toxicity and efficacy, as well as the effectiveness of new cosmetic ingredients. The company has collaborated on projects to develop complex bio-printed products, such as bioprinting hair follicles with L'Oréal. Poietis' single-cell bioprinting platform is designed to meet industrial production requirements and clinical manufacturing standards.
Naïo Technologies
Seed Round in 2015
Naïo Technologies SAS, founded in 2011 and based in Ramonville Saint Agne, France, specializes in the design and development of electric tools and robots for agriculture and viticulture. The company focuses on creating innovative machines for mechanical weeding, hoeing, and harvesting, aimed at enhancing farming efficiency while minimizing reliance on chemical pesticides and herbicides. By providing solutions that help farmers optimize their workload and profitability, Naïo Technologies also emphasizes reducing the environmental impact of agricultural practices. With a strong commitment to advancing agricultural technology, the company integrates elements of artificial intelligence and robotics into its product offerings, supporting sustainable farming practices.
GAIDDON
Seed Round in 2015
Founded in 2010 by 4 entrepreneurs, GAIDDON Software SAS is a simplified joint-stock company registered under French law with a share capital of 161,100 Euros. It is based in Toulouse, south of France. GAIDDON Software is integrated within the Toulouse Metropole business incubator since its creation. In 2011, the company gained the french label “Jeune Entreprise Innovante” from the ministry of higher education and research. It indicates that most of the work done by the company is an innovative research and development. This innovative work is our 3D environment builder technology from aerial/satellite imagery.
MyFeelBack
Venture Round in 2014
MyFeelBack is a developer of an innovative online customer survey and feedback platform that enables businesses to gather valuable insights about their customers. The platform allows companies to continuously update their customer databases and collect high-quality feedback, which facilitates data-driven decision-making. By asking targeted questions and displaying relevant messages to users based on their behavior, MyFeelBack empowers businesses to understand their customers deeply. This capability helps organizations identify areas for improvement, spot emerging trends, and implement personalized marketing strategies, ultimately driving sales conversion and enhancing growth.
Antabio
Seed Round in 2012
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.
Intuiface
Seed Round in 2011
Intuiface is a no-code platform that specializes in creating, integrating, deploying, and analyzing interactive digital experiences for physical spaces. Serving over 1,600 companies in more than 70 countries, it enables organizations across various industries, including retail, hospitality, real estate, tourism, and education, to engage audiences through interactive technologies. The platform supports diverse options such as touch, RFID/NFC, computer vision, and Internet of Things integration, allowing businesses to build and measure tactile digital experiences on a range of devices, from tablets to kiosks and video walls, without any programming expertise. Intuiface is also ISO 27001 Certified, ensuring a high standard of security for its users.
Antabio
Seed Round in 2011
Antabio is a private biopharmaceutical company based in Labege, France, focused on developing innovative treatments for drug-resistant infections, particularly targeting critical priority pathogens. Founded in 2009, the company specializes in creating novel antibacterial resistance-breakers, including stand-alone inhibitors of bacterial metalloenzymes. These inhibitors are designed to be combined with existing antibiotics, such as carbapenems, to restore their efficacy against the most challenging pathogens responsible for life-threatening infections, including carbapenem-resistant nosocomial pneumonia. Antabio aims to address significant unmet medical needs in the treatment of drug-resistant infections, ultimately providing healthcare professionals with effective medicinal products to combat these critical health challenges. The company has been recognized for its work, receiving a Wellcome Trust Seeding Drug Discovery Award.
Noomeo
Venture Round in 2009
Noomeo is a pioneering company established in 2007, focused on providing innovative 3D scanning solutions for businesses seeking user-friendly and portable systems. The company specializes in non-contact 3D digitization, enabling companies to integrate this technology into their processes efficiently and cost-effectively. Noomeo's commitment to research and development, in collaboration with esteemed research institutions, allows it to continually enhance its offerings. The company has developed advanced hardware solutions, known as OptiNum, and accompanying software, called NumiSoft, which automate the creation of 3D mock-ups. Through these innovations, Noomeo positions itself as a leader in the field of 3D digitization, catering to the evolving needs of various industries.